Nicotine Polacrilex, Original
NDC Package 68016-282-50
Package Information
Nicotine Polacrilex, Original is if you are under 18 years of age, ask a doctor before usebefore using this product, read the enclosed User's Guide for complete directions and other important information begin using the gum on your quit day if you smoke your first cigarette within 30 minutes of waking up, use 4 mg nicotine gum if you smoke your first cigarette more than 30 minutes after waking up, use 2 mg nicotine gum according to the following 12 week schedule: Weeks 1 to 6 Weeks 7 to 9 Weeks 10 to 12 1 piece every1 to 2 hours 1 piece every2 to 4 hours 1 piece every4 to 8 hoursnicotine gum is a medicine and must be used a certain way to get the best results chew the gum slowly until it tingles. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-282 and is authorized under FDA application ANDA074507.
Identification & Billing
- RxCUI: 311975 - nicotine polacrilex 4 MG Chewing Gum
- RxCUI: 311975 - nicotine 4 MG Chewing Gum
- RxCUI: 311975 - nicotine 4 MG (as nicotine polacrilex 22.2 MG) Chewing Gum
- RxCUI: 314119 - nicotine polacrilex 2 MG Chewing Gum
- RxCUI: 314119 - nicotine 2 MG Chewing Gum
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc
- 68016-282 - Nicotine Polacrilex, Original
- 68016-282-50 - 5 BLISTER PACK in 1 CARTON / 10 GUM, CHEWING in 1 BLISTER PACK
- 68016-282 - Nicotine Polacrilex, Original
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-282-50 identifies a specific commercial package of 5 blister pack in 1 carton / 10 gum, chewing in 1 blister pack of Nicotine Polacrilex, Original, labeled by Chain Drug Consortium, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 5 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc on September 01, 2013. The current certification is valid through September 30, 2018.
How is this Chain Drug Consortium, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016028250. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.